Board of Directors

Michael Mengel HeadshotMichael Mengel
President

Li Ka Shing Centre for Health Research
Edmonton, AB

Dr. Mengel is Chair of the Department for Laboratory Medicine and Pathology at the University of Alberta, Edmonton, Canada. He is a sub-specialized Transplantation and Renal Pathologist at the Division of Anatomical Pathology, University of Alberta Hospital. Outside his faculty Dr. Mengel is engaged in various international sub-specialty societies related to nephropathology and organ transplantation: past Chair Transplant Diagnostics Community of Practice in the American Society of Transplantation; Board member International Banff Foundation for Allograft Pathology; Board member Canadian Society of Transplantation; past Chair Program Committee International Renal Pathology Society.

He studied medicine at the Semmelweiss University in Budapest, Hungary before going on to specialise in pathology and further in transplantation pathology and nephropathology. Before moving to Edmonton he was head of the transplant pathology service at the Hannover Medical School, Germany. In Edmonton, Dr. Mengel’s current work is focused on applying molecular techniques to biopsy specimens, with the aim to increase diagnostic precision in the area of organ transplantation.


Tinckam headshot 2Kathryn Tinckam
Vice President

Division of Nephrology and HLA Laboratory, University Health Network
University of Toronto
Toronto, ON

Dr. Kathryn Tinckam is a Transplant Nephrologist and Co-Director of the Histocompatibility Laboratory at the University Health Network in Toronto since 2007. She is also Medical Advisor – Transplantation at Canadian Blood Services with responsibilities in Listing and Allocation, Kidney Paired Donation, the Highly Sensitized Patient Program, and the Canadian Transplant Registry.

She completed her undergraduate medical and Internal Medicine residency training at the University of Manitoba, Nephrology and Transplant fellowships at the University of British Columbia and Histocompatibility and Immunogenetics Training at Harvard University.

Dr. Tinckam’s clinical and research focus is in the diagnosis and management of antibody mediated processes in organ transplantation, and in the standardization and optimized utilization of HLA laboratory testing in clinical practice.


Dr_Joseph_Kim_Headshot.jpgS. Joseph Kim
Secretary-Treasurer

Toronto General Hospital, University Health Network
University of Toronto
Toronto, ON

Dr. S. Joseph Kim is a staff nephrologist in the Division of Nephrology and co-director of the Kidney Transplant Program at the Toronto General Hospital, University Health Network. He is also an Assistant Professor in the Department of Medicine and the Institute of Health Policy, Management and Evaluation at the University of Toronto.

He is the President of the Canadian Organ Replacement Register Board of Directors, Vice-Chair of the U.S. Organ Procurement and Transplantation Network Data Advisory Committee, and the Associate Head of the Kidney, Dialysis and Transplantation program at the Institute for Clinical Evaluative Sciences.

Dr. Kim completed medical school, internal medicine residency, chief medical residency, and fellowships in nephrology and kidney transplantation at the University of Toronto. In 2008, he completed a PhD in epidemiology and a Masters in biostatistics at the Johns Hopkins Bloomberg School of Public Health.

His research interests are in the areas of access to and outcomes of kidney transplantation using data from both centre- and population-based cohorts. His methodological interests include survival analysis and statistical models for causal inference.


PicAtul Humar
Past President

Multi Organ Transplant Program Toronto General Hospital
Toronto, ON

Atul Humar is a Professor in the Department of Medicine, University of Toronto. Dr. Humar received his medical degree from the University of Ottawa. He completed his residency and did further training in Transplant Infectious Diseases in Toronto and Boston. Dr. Humar’s research interests are in virology with a focus on the pathogenesis of herpesvirus infections post-transplant. He is involved in both basic and clinical research assessing immunologic and virologic determinants of infection. Dr. Humar is the Director of Multi Organ Transplant Program at the University Health Network and the University of Toronto Transplant Institute. He is also active in the Canadian Society of Transplantation as a President and has been very active in both the AST and TTS. Dr. Humar operates a joint research lab with his wife, Dr. Deepali Kumar, who is also a faculty member at the University of Toronto.

 

 


BFoster.jpegBethany Foster
Director

McGill University
Montreal, QC

Dr. Bethany Foster is a Pediatric Nephrologist and Clinical Epidemiologist and an Associate Professor of Pediatrics at McGill University. She commits about 70% of her time to research activities, 25% to clinical care, and the remaining time to teaching. Her primary research interest is in the long term outcomes of children and young adults with kidney transplants. Dr. Foster’s research focuses in particular on adolescent and young adult kidney transplant recipients, whom she has identified to be at particularly high risk of graft loss. Graft losses in this interval are often due to poor adherence to immunosuppressive medication related to developmental stage and possibly to the changes in care practices associated with transfer from pediatric to adult-oriented care. Recently, she has extended her studies of young transplant recipients to heart and liver recipients.

Dr. Foster is currently leading a multi-centre study funded by the U.S. National Institutes of Health to test an intervention to improve medication adherence among 11 to 24 year-old kidney transplant recipients. She is also the co-lead of the Canadian National Transplant Research Program (CNTRP) POSITIVE study, which focuses on children and adolescents with solid organ transplants. Within the POSITIVE study, Dr. Foster leads a Canadian national cohort study to identify care processes and structures that promote better adherence among young solid organ transplant recipients. This study is unique in that it includes both pediatric and adult transplant programs. She also has extensive experience conducting studies using large databases such as the United States Renal Data Systems database and the Scientific Registry of Transplant Recipients.

At the McGill University Health Centre, Dr. Foster is the Associate Director of the Centre for Innovative Medicine, which provides investigators with the infrastructure and personnel to conduct patient-oriented research. She is also a member of the Child Health Research Advisory committee. At McGill University, Dr. Foster teaches epidemiology to both graduate and medical students, and renal physiology to medical students.


AGoldberg.jpegAviva Goldberg
Director

University of Manitoba
Winnipeg, MB

Dr. Aviva Goldberg is a Pediatric Nephrologist in Winnipeg, Manitoba and head of the Section of Pediatric Nephrology in the Department of Pediatrics and Child Health at the University of Manitoba. She completed her fellowship in pediatric nephrology at the University of Manitoba in 2004, and did further training in pediatric nephrology and transplantation at Northwestern University’s McGaw Medical Center/ Children’s Memorial Hospital (now Lurie Children’s) from 2004-2006. She is also an ethicist, and completed a Master’s degree in Bioethics and Health Policy at Loyola University Chicago and a clinical ethics fellowship at Northwestern University’s Feinberg School of Medicine.

Dr. Goldberg contributes to the Canadian transplant community clinically, through scholarly activity, and as an administrator. She is a member of the CNTRP, and has recently co-edited the first book on pediatric transplant ethics (to be published in 2016) and is Chair of the Kidney Transplant Review Committee of Transplant Manitoba.  She lectures nationally and internationally on ethics and transplantation, including sessions at the CST, CSN, AST, WTC, IPTA, ESOT, PAS and Kidney Foundation and invited rounds at several Canadian and American universities.


JSchiff.jpegJeffrey Schiff
Director

Toronto General Hospital, University Health Network
Toronto, ON

Dr. Jeffrey Schiff completed his medical school, Internal Medicine and Nephrology training at McGill University, followed by a fellowship in kidney and pancreas transplantation at McGill University and Hôpital Notre-Dame. In 2004, he joined the Division of Nephrology and the Multi-Organ Transplant Program at the Toronto General Hospital, University Health Network (UHN).  He is an Assistant Professor of Medicine at the University of Toronto.

Dr. Schiff is a member of the Kidney Transplant Program and Medical Director of the Pancreas and Islet Transplant Programs at UHN. He currently leads the renal transplant desensitization program and championed a transition program for pediatric renal transplant recipients. He has also worked with other organizations that play a role in transplant including Canadian Blood Services as chair of the Pancreas/Islets Data Working Group; Trillium Gift of Life Network as an on-call Transplant Support Physician; and the Ontario Regional Blood Coordinating Network in developing guidelines for the use of IVIg.
Dr. Schiff is heavily involved in educating the next generation of transplant professionals. He is the Program Director for the Adult Renal Transplant Fellowship at UHN and the chair of the CST Education Committee. He has also developed free web-based educational resources in transplantation.


MC_Fortin.jpg Marie-Chantal Fortin
 Director

 CHUM
 Montreal, QC

 Marie-Chantal Fortin, M.D., Ph.D., F.R.C.P.(c) is a transplant nephrologist at the Centre hospitalier de   l’Université de Montréal (CHUM), a researcher at the Research Center of the CHUM and an associate   professor at the Faculty of Medicine of the Université de Montréal. She received her medical degree from   the Université de Sherbrooke. She completed her nephrology residency at the Université de Montréal. She   has completed a PhD in bioethics in 2008 at the Université de Montréal.

 She is also a researcher within the Canadian National Transplant Research Program (CNTRP) and the co-   leader of the Core 4 (the patient-researcher partnership platform). Her research interests are related to   transplantation ethics and patient and researcher partnership in research and clinical care. She chairs the   ethics committee of the Canadian Society of Transplantation and she is a member of the ethics committee   of Transplant Québec, the Royal College of Physicians and Surgeons of Canada, the Canadian Blood   Services andthe Collège des médecins du Québec. Finally, she is also a research scholar of the FRQS.


JagGillHeadShot.jpgJagbir Gill
 
Director

UBC
Vancouver, BC

Dr. Jag Gill is an Associate Professor of Medicine in the Division of Nephrology at the University of British Columbia. He is a transplant nephrologist at St. Paul’s Hospital in Vancouver and is Medical Director of Data and Quality at B.C. Transplant. He is Vice-President of the Canadian Organ Replacement Register Board of Directors and is a Michael Smith scholar and research scientist at the Centre for Health Evaluation and Outcomes Sciences. He conducts health outcomes research in organ donation and transplantation. He holds peer-reviewed grant funding from CIHR, BC Transplant Research Foundation, and the Kidney Foundation of Canada. He has served the Canadian Society of Transplantation as Chair of the CST ASM Planning and the Communications committees, and is currently an active member of additional CST committees, including the CST Research Committee.

 

 



ProsantoChoudhury.jpgProsanto Choudhury

 Director

UBC
Vancouver, BC

Dr Chaudhury joined the Department of Surgery of McGill University in July 2007 after completing Fellowship training in Transplantation and HPB both here at McGill and at Northwestern University in Chicago. He received my Master’s degree in Evidence-based Health Care from the University of Oxford in the Fall of 2007. Since His return, his clinical activities have been based at the Royal Victoria Hospital and have centered on the treatment of complex hepato-pancreato-biliary oncology and organ transplantation. He is currently cross-appointed to the departments of Surgery and Oncology as Associate Professor.

 

 

 


RameshPrasad.jpgRamesh Prasad
 Director

St. Michael’s Hospital
Toronto, ON

Dr. Prasad obtained his medical degree from Osmania University, India. He obtained his training in Internal Medicine at Wayne State University-Detroit Medical Center, Nephrology at the University of Pittsburgh Medical Center, and Transplantation Nephrology at Toronto General Hospital. He holds a Master of Science degree from the Institute of Medical Science, University of Toronto and PhD degree in Philosophy from the University of Waterloo. He is Director of the Kidney Transplant Program at St. Michael’s Hospital, Fellow of the American Societies of Transplantation, Nephrology, and Hypertension; and a Professor of Medicine at the University of Toronto.